Acute liver injury,acute liver failure and acute on chronic liver failure: A clinical spectrum of poisoning due to Gyromitra esculenta

Gyromitra esculenta, also known as “false morel” is one of the most poisonous mushrooms. This species is found all over the world, growing in coniferous forest in early spring time. Common manifestation of poisoning includes gastrointestinal symptoms which include varied degrees of liver impairment.We describe three cases: acute liver injury, acute liver failure and acute-on-chronic liver failure due to G. esculenta poisoning. At admission patients presented with encephalopathy and features of liver failure. Two of them recovered completely following supportive management while the remaining patient who also had preexisting liver disease developed multiorgan failure and subsequently died.Although a rare occurrence, G. esculenta poisoning should be considered in the differential diagnosis of acute liver failure.     

急性一氧化碳中毒后迟发性脑病的临床表现和影像学特点

目的探讨急性一氧化碳中毒后迟发性脑病的临床表现和影像学特点及其诊断价值。方法回顾性对23例急性一氧化碳中毒后迟发性脑病的临床表现和影像学特点进行归纳和分析。结果23例患者中智能障碍23例（100％），言语功能障碍17例（73.9％），另有共济失调精神障碍帕金森综合症及尿失禁等。头部CT和MRI主要表现为皮层下脑白质异常信号及基底节区或苍白球区异常信号，极少累及大脑皮质脑干和小脑。结论急性一氧化碳中毒后迟发性脑病的诊断主要依靠病史和临床症状，MRI比CT更有诊断价值。     

存样食物在追查食物中毒源头中的作用

[目的]针对食物中毒事件追查源头的困难局面,探索1种新的食物中毒追查方法。[方法]通过分析各种常见类型食物中毒的潜伏期,结合各种实际情况,探讨存样食物保存的时间和方法。[结果]存样食物至少要保存24h。[结论]这种存样待检方法有其先进性,但仍存在不少问题,需进一步改进。     

CS_2作业工人血清脂质过氧化水平与LDH同功酶谱研究

ＣＳ_２作业工人血清脂质过氧化水平与ＬＤＨ同功酶谱研究张文昌，连祥霖，张连娜，杨乃富（福建医学院劳动卫生学教研室，福州３５０００４）结果表明，高接触水平组（浓度为１０．４２～４６．５４ｍｇ／ｍ３或Σｍｇ·年≥５０）血清ＬＰＯ含量与对照比较，显著性增高?..     

气管切开与呼吸机机械通气抢救有机磷农药中毒致呼吸肌麻痹6例

目的：探讨气管切开与呼吸机机械通气抢救重度有机磷农药中毒（ＡＯＰＰ）致呼吸肌麻痹的疗效。方法：对６例重度ＡＯＰＰ致呼吸肌麻痹患者在综合治疗基础上，及时予气管切开，并使用全能呼吸机机械通气。结果：治愈５例，死亡１例。抢救成功率达８３．３％。结论：对重度ＡＯＰＰ患者及时行气管切开，并使用全能呼吸机机械通气，抢救效果良好。     

Nerve agent poisoning in primates: antilethal, anti-epileptic and neuroprotective effects of GK-11

 Organophosphorus nerve agents are still in use today in warfare and as terrorism compounds. Classical emergency treatment of organophosphate poisoning includes the combined administration of a cholinesterase reactivator (an oxime), a muscarinic cholinergic receptor antagonist (atropine) and a benzodiazepine anticonvulsant (diazepam). However, recent experiments with primates have demonstrated that such treatment, even when administered immediately after organophosphate exposure, does not rapidly restore normal electroencephalographic (EEG) activity and fails to totally prevent neuronal brain damage. The objective of this study was to evaluate, in a realistic setting, the therapeutic benefit of administration of GK-11 (gacyclidine), an antiglutamatergic compound, as a complement to the available emergency therapy against organophosphate poisoning. GK-11 was injected at a dose of 0.1 mg/kg (i.v) after a 45-min latency period to heavily intoxicated (8 LD₅₀) primates. Just after intoxication, man-equivalent doses of one autoinjector containing atropine/pralidoxime/diazepam were administered. The effects of GK-11 were examined on survival, EEG activity, signs of toxicity, recovery after challenge and central nervous system histology. The present data demonstrate that treatment with GK-11 prevents the mortality observed after early administration of classical emergency medication alone. EEG recordings and clinical observations also revealed that GK-11 prevented soman-induced seizures and motor convulsions. EEG analysis within the classical frequency bands (beta, theta, alpha, delta) demonstrated that central activity was totally restored to normal after GK-11 treatment, but remained profoundly altered in animals receiving atropine/pralidoxime/diazepam alone. GK-11 also markedly accelerated clinical recovery of soman-challenged primates. Lastly, this drug totally prevented the neuropathology observed 3 weeks after soman exposure in animals treated with classical emergency treatment alone. GK-11 represents a promising adjuvant therapy to the currently available emergency polymedication to ensure optimal management of organophosphate poisoning in man. This drug is presently being evaluated in a human clinical trial for a different neuroprotective indication. Received: 16 June 1997 / Accepted: 23 September 1997     

铅性肾病的流行病学分析

我们检查了铅接触人员１０２３名，发现铅性肾病８４例，患病率８．２％。女性３４例（７．２％），男性５０例（９％），男女铅性肾病患病率无显著性差异。印刷厂空气铅浓度平均０．００６９ｍｇ／ｍ３，蓄电池厂为０．１００５ｍｇ／ｍ３，铅矿为０．５ｍｇ／ｍ３。铅性肾病患病率分别为４．７３％，８．３％和２８．５７％（Ｐ＜０．００５）。分析铅性肾病患病率与年龄和铅接触年限的关系。年龄小于３０岁，～４０岁，～５０岁和大于５０岁者，铅性肾病患病率分别为５．５％，８．６％，１２．１％，和１５．６％（Ｐ＜０．０５）。铅接触年限小于１０年，～２０年和大于２０年者，铅性肾病患病率分别为６．６％，９．９％和１３．１％（Ｐ＜０．０５）。     

一氧化碳中毒迟发性脑病的临床预防

目的　探讨临床治疗措施对一氧化碳中毒迟发性脑病的预防。方法　将 130例一氧化碳中毒患者随机分为A、B、C 3组 ,A组采用纳络酮、低分子肝素、高压氧治疗 ;B组采用胞二磷胆碱、醒脑注射液、高压氧治疗 ;C组采用胞二磷胆碱、醒脑注射液治疗。结果　A组昏迷时间与B、C组对比 ,B组与C组对比 ,明显缩短 ,有显著性差异 (P <0 .0 5或P <0 .0 1) ;本组 130例患者中 ,共发生迟发性脑病15例 ,发生率为 11.5 % ,迟发性脑病发生率A组与B、C组对比 ,B组与C组对比 ,明显降低 ,有显著性差异 (P <0 .0 5或P <0 .0 1)。结论　选择有效的药物 ,及早应用高压氧和充足的疗程是迟发性脑病临床预防的关键。     

职业性慢性轻度苯中毒诊治分析

目的 对长期慢性接触苯及同系物患者进行职业病诊断.方法 依据卫生部《职业健康监护管理办法》中的《职业健康检查项目及周期》中的要求,对患者进行职业健康检查,依据GBZ68-2002《职业性苯中毒诊断标准》的有关规定对患者进行复查.结果 该患者在3个月内每1～2周复查1次全血,白细胞计数持续低于4×109/L并常有头晕、头痛、乏力、失眠、记忆力减退等症状,依据GBZ68-2002《职业性苯中毒诊断标准》诊断为职业性慢性轻度苯中毒.结论 长期慢性接触苯可引起造血系统损害.     

营养性驱铅饮料的研究

本文研究营养性驱铅饮料的动物和人群试验。饮料与铅料动物组间比较,饮料组动物的尿、粪排铅量高,分别是对照组的1.5倍和1.1倍;血、肝、肾中含量低;体内 Zn、Cu、Fe 等微量元素基本稳定。其体重增长与对照组相一致。人群试验:试验组尿铅排出明显,试验末(2月后)仅为试验初的21.7%;血铅平均减少0.39μmol/l;血中 Hb、δ-ALAD 和尿中δ-ALA 等均恢复良好;不影响体内Zn、Cu 等微量元素,无不良反应。